Introduction
Building production-ready agentic AI solutions can present significant challenges—from navigating complex architectures to establishing clear development patterns. The life sciences industry adds further complexity: strict regulations, diverse data modalities, and the variety of diseases all require additional time and specialized approaches. At AWS, we believe there’s a better path forward.
AWS continues to invest in AI tools that accelerate the time from agentic AI development to production and make it easier for scientists to harness the full power of AI regardless of their technical background. Since launching mid-2025, life sciences customers have turned to Kiro – the first AI coding tool built around specification driven (spec-driven) development – to accelerate use cases across the value chain, from R&D workflows like target identification and clinical trial design to commercial operations like 340B revenue protection, reducing…
